Market Overview

UPDATE: JP Morgan Upgrades Aetna to Overweight on Revised Numbers Post Deal Closure

Share:
Related AET
Goldman Adds Cigna To Conviction Buy List, Expects DoJ Announcement To Refocus Investors On Standalone Merits
JPMorgan Downgrades Humana Following Deal Reports

JP Morgan raised its rating on Aetna (NYSE: AET) from Neutral to Overweight and increased its price target from $46 to $52.

JP Morgan said, "We are upgrading Aetna to Overweight from Neutral and raising our price target from $46 to $52 on the expectation of upwardly revised numbers post CVH deal closing, AET's below-average reform exposure and most importantly an increasing recognition of the company's ACO positioning. From a catalyst perspective, at next Wednesday's investor day we expect initial 2013 EPS guidance in the $5.40 range (JPM $5.40, consensus $5.51), within the range of investor expectations."

Aetna closed at $43.43 on Thursday.

Latest Ratings for AET

DateFirmActionFromTo
Jul 2016Wolfe ResearchDowngradesOutperformPeer Perform
Jun 2016BernsteinInitiates Coverage onOutperform
Apr 2016ClevelandInitiates Coverage onNeutral

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (AET)

View Comments and Join the Discussion!